Body dysmorphic disorder and oxytocin

Body dysmorphic disorder and oxytocin

The current project aims to investigate the effect of acute intranasal oxytocin administration on social and emotional brain regions in BDD. Twenty male and female patients with a diagnosis of BDD, and twenty demographically matched healthy participants will undergo magnetic resonance imaging (MRI) after receiving both oxytocin and placebo nasal spray a month apart, in a double-blind, placebo controlled, randomised clinical trial. Participants will also complete a clinical interview and a range of baseline measures of cognitive functioning and visual perception. Conclusive findings from this research have important implications for understanding the neurobiology of BDD, and have the potential to advance future therapeutic treatments in the disorder.

Avatar
Sally Grace
Postdoctoral Researcher

Investigating cognition and social behavior in mental illness using MRI.

Publications